Cellular thermal shift assay (CETSA) is a valuable method to confirm target engagement within a complex cellular environment, by detecting changes in a protein's thermal stability upon ligand binding. The classical CETSA method measures changes in the thermal stability of endogenous proteins using immunoblotting, which is low-throughput and laborious. Reversephase protein arrays (RPPAs) have been demonstrated as a detection modality for CETSA; however, the reported procedure requires manual processing steps that limit throughput and preclude screening applications. We developed a high-throughput CETSA using an acoustic RPPA (HT-CETSA-aRPPA) protocol that is compatible with 96-and 384-well microplates from start-tofinish, using low speed centrifugation to remove thermally destabilized proteins. The utility of HT-CETSA-aRPPA for guiding structure−activity relationship studies was demonstrated for inhibitors of lactate dehydrogenase A. Additionally, a collection of kinase inhibitors was screened to identify compounds that engage MEK1, a clinically relevant kinase target.
Determining a molecule’s mechanism of action is
paramount
during chemical probe development and drug discovery. The cellular
thermal shift assay (CETSA) is a valuable tool to confirm target engagement
in cells for a small molecule that demonstrates a pharmacological
effect. CETSA directly detects biophysical interactions between ligands
and protein targets, which can alter a protein’s unfolding
and aggregation properties in response to thermal challenge. In traditional
CETSA experiments, each temperature requires an individual sample,
which restricts throughput and requires substantial optimization.
To capture the full aggregation profile of a protein from a single
sample, we developed a prototype real-time CETSA (RT-CETSA) platform
by coupling a real-time PCR instrument with a CCD camera to detect
luminescence. A thermally stable Nanoluciferase variant (ThermLuc)
was bioengineered to withstand unfolding at temperatures greater than
90 °C and was compatible with monitoring target engagement events
when fused to diverse targets. Utilizing well-characterized inhibitors
of lactate dehydrogenase alpha, RT-CETSA showed significant correlation
with enzymatic, biophysical, and other cell-based assays. A data analysis
pipeline was developed to enhance the sensitivity of RT-CETSA to detect
on-target binding. RT-CETSA technology advances capabilities of the
CETSA method and facilitates the identification of ligand-target engagement
in cells, a critical step in assessing the mechanism of action of
a small molecule.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.